Image

    Nanospanlastic Vesicles as Novel Strategies for Enhancing Anti-Glaucoma Drug Bioavailability

    January 2025 in “ The Pharma Innovation ”
    Siddharth S. Kesharwani, Poonam Maurya
    Studysummary This review discusses how nanospanlastics, a type of ultra deformable vesicular nanocarrier, could enhance glaucoma management by improving the delivery and effectiveness of intraocular pressure-lowering agents, tackling adherence challenges, and advancing targeted therapies, according to the authors.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on thepharmajournal.com →
    Discuss this study in the Community →